FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2581890175> ?p ?o ?g. }

• W2581890175 abstract "Abstract Abstract 4254 BCR/ABL-positive cells are relatively resistant to chemotherapy and, in order to evaluate the effect of Imatinib (IM) in reverting drug-resistance, we evaluated on K562 the toxicity of 1 h exposure to cytosine arabinoside (ARA-C) 20 μM, hydroxyurea (HU) 100 μM, and melphalan (MEL) 20 μM, after a pre-treatment of 24 h with 1 μM IM. The doses of the drugs were similar to that achieved in the plasma after standard chemoterapeutic treatment. Cell viability was evaluated by ATP-lite at 24, 48 and 72 hs from beginning of drug-free condition. The combinations of IM plus MEL induced the highest cytotoxicity (P<0,001 at 24, 48 and 72 hs vs MEL alone) indicating that pre-treatment with IM increased K562 exposition to the genotoxic damage of MEL. We next analyzed effects on cell cycle and DNA damage by alkaline comet assay induced by this drug combination and we observed that DNA damage peaked at 48 h with IM/MEL combination. In addition, flow cytometry analysis showed that IM/MEL combination reduced the cell accumulation in G2/M phase induced by MEL (P<0.001 vs MEL), thus reducing the ability to DNA repair and recovery. These data indicate that inhibition of BCR/ABL activity by IM increased cell cytotoxicity of MEL by reducing the effectiveness of the DNA-repair pathways and decreasing the time for DNA repair at the G2/M checkpoint.. To ascertain that these results were linked to BCR/ABL inhibition, TonB.210, a cell line where the BCR-ABL expression is inducible by doxycycline (DOX), were treated in the same conditions. Only TonB.210 cultured with DOX were insensitive to MEL while IM/MEL combination reverted these drug resistance (P<0,001). In the final step we studied the sequential association IM/MEL on the proliferative potential of myeloid progenitors of 6 CML patients at diagnosis. IM/MEL combination increased the reduction of the overall number of colonies in comparison to IM alone (P<0.05 vs IM). In addition, the analysis on CFU-GM and BFU-E colonies by qRT-PCR demonstrated that the IM/MEL combination led to the highest reduction in the number of BCR/ABL positive colonies (P<0.01 vs IM). Therefore, our data indicate that the pre-inhibition of BCR/ABL activity by IM increases the toxicity of MEL and allows an efficient killing of human leukemic cells, thus suggesting new therapeutic combinations for CML patients Disclosures: No relevant conflicts of interest to declare." @default.
• W2581890175 created "2017-02-03" @default.
• W2581890175 creator A5003820498 @default.
• W2581890175 creator A5007753833 @default.
• W2581890175 creator A5030208971 @default.
• W2581890175 creator A5034393745 @default.
• W2581890175 creator A5038163660 @default.
• W2581890175 creator A5040930723 @default.
• W2581890175 creator A5043599930 @default.
• W2581890175 creator A5065852754 @default.
• W2581890175 creator A5070046619 @default.
• W2581890175 creator A5072417532 @default.
• W2581890175 creator A5074845589 @default.
• W2581890175 creator A5078005763 @default.
• W2581890175 creator A5078324992 @default.
• W2581890175 date "2009-11-20" @default.
• W2581890175 modified "2023-09-30" @default.
• W2581890175 title "Imatinib Increases Cytotoxicity of Melphalan and Their Combination Allows An Efficient Killing of CML Cells." @default.
• W2581890175 doi "https://doi.org/10.1182/blood.v114.22.4254.4254" @default.
• W2581890175 hasPublicationYear "2009" @default.
• W2581890175 type Work @default.
• W2581890175 sameAs 2581890175 @default.
• W2581890175 citedByCount "0" @default.
• W2581890175 crossrefType "journal-article" @default.
• W2581890175 hasAuthorship W2581890175A5003820498 @default.
• W2581890175 hasAuthorship W2581890175A5007753833 @default.
• W2581890175 hasAuthorship W2581890175A5030208971 @default.
• W2581890175 hasAuthorship W2581890175A5034393745 @default.
• W2581890175 hasAuthorship W2581890175A5038163660 @default.
• W2581890175 hasAuthorship W2581890175A5040930723 @default.
• W2581890175 hasAuthorship W2581890175A5043599930 @default.
• W2581890175 hasAuthorship W2581890175A5065852754 @default.
• W2581890175 hasAuthorship W2581890175A5070046619 @default.
• W2581890175 hasAuthorship W2581890175A5072417532 @default.
• W2581890175 hasAuthorship W2581890175A5074845589 @default.
• W2581890175 hasAuthorship W2581890175A5078005763 @default.
• W2581890175 hasAuthorship W2581890175A5078324992 @default.
• W2581890175 hasConcept C109316439 @default.
• W2581890175 hasConcept C125418893 @default.
• W2581890175 hasConcept C170493617 @default.
• W2581890175 hasConcept C171122931 @default.
• W2581890175 hasConcept C202751555 @default.
• W2581890175 hasConcept C203014093 @default.
• W2581890175 hasConcept C2776364478 @default.
• W2581890175 hasConcept C2777583451 @default.
• W2581890175 hasConcept C2778461978 @default.
• W2581890175 hasConcept C2778684742 @default.
• W2581890175 hasConcept C2778729363 @default.
• W2581890175 hasConcept C3019892230 @default.
• W2581890175 hasConcept C42362537 @default.
• W2581890175 hasConcept C502942594 @default.
• W2581890175 hasConcept C55493867 @default.
• W2581890175 hasConcept C86803240 @default.
• W2581890175 hasConcept C98274493 @default.
• W2581890175 hasConceptScore W2581890175C109316439 @default.
• W2581890175 hasConceptScore W2581890175C125418893 @default.
• W2581890175 hasConceptScore W2581890175C170493617 @default.
• W2581890175 hasConceptScore W2581890175C171122931 @default.
• W2581890175 hasConceptScore W2581890175C202751555 @default.
• W2581890175 hasConceptScore W2581890175C203014093 @default.
• W2581890175 hasConceptScore W2581890175C2776364478 @default.
• W2581890175 hasConceptScore W2581890175C2777583451 @default.
• W2581890175 hasConceptScore W2581890175C2778461978 @default.
• W2581890175 hasConceptScore W2581890175C2778684742 @default.
• W2581890175 hasConceptScore W2581890175C2778729363 @default.
• W2581890175 hasConceptScore W2581890175C3019892230 @default.
• W2581890175 hasConceptScore W2581890175C42362537 @default.
• W2581890175 hasConceptScore W2581890175C502942594 @default.
• W2581890175 hasConceptScore W2581890175C55493867 @default.
• W2581890175 hasConceptScore W2581890175C86803240 @default.
• W2581890175 hasConceptScore W2581890175C98274493 @default.
• W2581890175 hasLocation W25818901751 @default.
• W2581890175 hasOpenAccess W2581890175 @default.
• W2581890175 hasPrimaryLocation W25818901751 @default.
• W2581890175 hasRelatedWork W2063804742 @default.
• W2581890175 hasRelatedWork W2123339281 @default.
• W2581890175 hasRelatedWork W2134288099 @default.
• W2581890175 hasRelatedWork W2166687484 @default.
• W2581890175 hasRelatedWork W2385410559 @default.
• W2581890175 hasRelatedWork W2395175181 @default.
• W2581890175 hasRelatedWork W2460693764 @default.
• W2581890175 hasRelatedWork W2463764793 @default.
• W2581890175 hasRelatedWork W2529971935 @default.
• W2581890175 hasRelatedWork W2535211482 @default.
• W2581890175 hasRelatedWork W2535395627 @default.
• W2581890175 hasRelatedWork W2547251167 @default.
• W2581890175 hasRelatedWork W2557014216 @default.
• W2581890175 hasRelatedWork W2557051291 @default.
• W2581890175 hasRelatedWork W2559877690 @default.
• W2581890175 hasRelatedWork W2562209710 @default.
• W2581890175 hasRelatedWork W2732231164 @default.
• W2581890175 hasRelatedWork W2980185999 @default.
• W2581890175 hasRelatedWork W3030533539 @default.
• W2581890175 hasRelatedWork W656370487 @default.
• W2581890175 isParatext "false" @default.
• W2581890175 isRetracted "false" @default.
• W2581890175 magId "2581890175" @default.
• W2581890175 workType "article" @default.